The largest database of trusted experimental protocols

Reducing sample buffer

Manufactured by Bio-Rad
Sourced in Italy

Reducing sample buffer is a laboratory reagent used to prepare samples for protein analysis. It contains reducing agents that help denature and solubilize proteins, making them more accessible for analysis. The core function of this product is to prepare samples for downstream applications such as gel electrophoresis and Western blotting.

Automatically generated - may contain errors

12 protocols using reducing sample buffer

1

MR1 and HLA-A,B,C Protein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested in cell lysis buffer (50 mM NaCl, 50 mM TRIS pH8, 1% IGEPAL, 1% Triton X-100) supplemented with protease inhibitor cocktail (Sigma) and allowed to incubate on ice for 20 mins. Lysates were then centrifuged (16,000 × g for 20 min at 4°C) and the supernatant collected. Lysates were mock or Endo H (NEB) digested according to the manufacturer’s instructions for 90 mins at 37°C as required. Lysates were denatured by heating at 95°C for 5 mins in reducing sample buffer (Bio-Rad) and resolved by SDS-PAGE on precast polyacrylamide gels (Biorad) before immunoblotting onto PVDF membranes. Membranes were probed with the designated primary antibodies in 3% BSA in PBST, followed by incubation with an appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (all Santa Cruz Biotechnology). The following primary antibodies were utilized: anti-MR1 CT (McWilliam et al., 2016 (link)), anti-MR1 and anti-HLA-A, B, C (Abcam), anti-GFP, anti-GAPDH, anti-gD, and anti-ICP0 (all Santa Cruz Biotechnology).
+ Open protocol
+ Expand
2

Quantification of Liver Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
About 50 mg of frozen mouse liver tissue samples were homogenised in 650 µL of TNE buffer (10 mmol/L Tris-HCl (pH 7.5), 1% Nonidet P40, 150 mmol/L NaCl, 1 mmol/L EDTA) containing a cocktail of protease and phosphatase inhibitors (Roche). Lysates were incubated at 4°C for 45 min and then centrifuged at 12 000 g for 5 min. Protein content was quantified in the supernatant using BCA Protein Assay (Thermo Fisher). Lysates were mixed with the reducing sample buffer (Bio-Rad) for electrophoresis and subsequently transferred onto polyvinylidene fluoride membranes (Thermo Fisher). Equal loading (50 µg) was verified using Ponceau red solution. Membranes were incubated with anti-PPARα (1:1000, Ab24509, Abcam) antibody. After secondary antibody incubation (anti-rabbit, 1:3000; Amersham, GE Healthcare, Courtaboeuf, France), immunodetection proceeded using an enhanced chemiluminescence kit (Clarity Western ECl Substrate, BioRad, France) and bands were revealed using the Las-4000 Imaging System and Image MultiGauge software (Fujifilm, Tokyo, Japan). After initial immunodetection, membranes were stripped of antibodies and reprobed with mouse anti-GAPDH antibody (1:20 000; Millipore) and secondary antibody (anti-mouse, 1:3000; Amersham GE healthcare).
+ Open protocol
+ Expand
3

SDS-PAGE and Immunoblotting of Venoms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Electrophoresis of venoms in sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gels was carried out with 20% gels using Tris-Glycine as running buffer and stained with either Coomassie Brilliant Blue R-250 or silver staining, as outlined in [20 (link)]. For immunoblotting, venom samples (typically 10–15 μg protein) were solubilized in reducing sample buffer (BioRad), separated by SDS-PAGE, and subsequently transferred to nitrocellulose paper. Membranes were blocked with blocking buffer [1% (w/v) skimmed non-fat milk, 0.3% (v/v) Tween 20/PBS] for 1 h and then incubated with therapeutic sera from immunized horses, diluted in the same blocking buffer (1/1,000), for 1.5 h. Membranes were washed with 0.05% (v/v) Tween 20/PBS and incubated with goat anti-horse horseradish peroxidase-conjugated secondary antibody (Sigma) (diluted 1/50,000) in blocking buffer for 1 h. Membranes were washed once again and blots were developed using Luminata Forte Western HRP Substrate (Millipore).
+ Open protocol
+ Expand
4

Western Blot Analysis of Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Macrophages (106 per condition) were treated as indicated, washed once with ice cold PBS, and lysed with RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% NP–40, 0.5% sodium deoxycholate, 0.1% SDS) with addition of a protease and protein phosphatase inhibitor cocktail (Pierce, Rockford, IL). Lineage-depleted bone marrow cells and FACS-isolated bone marrow monocytes and granulocytes were lysed as above. Samples were boiled in reducing sample buffer (Bio-Rad) and run on SDS-PAGE gels (Bio-Rad), transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA), and blocked in 5% nonfat dry milk in PBS–0.1% Tween 20. Primary antibodies included anti-phospho-ERK1/2 (clone D13.14.4E), anti-ERK1/2 (clone 137F5), and anti-β-actin (clone D6A8) (all from Cell Signaling Technology, Danvers, MA). Primary antibodies were incubated in blocking buffer overnight at 4°C; membranes were then washed three times in PBS–0.1% Tween 20, treated with secondary antibody (horseradish peroxidase-linked goat anti-rabbit IgG, catalog number 7074, Cell Signaling Technology) in blocking buffer, washed three times, and treated with enhanced chemiluminescence reagent (Pierce). Membranes were exposed to film (Amersham GE Healthcare, Pittsburgh, PA), and images were scanned and analyzed. Densitometric analysis was performed using ImageJ software [17 (link)].
+ Open protocol
+ Expand
5

NR4A1 Protein Interactome Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-IP was performed using a universal magnetic Co-IP kit (Active motif) per manufacturer’s protocol. In brief, 5–10 million cells were collected and lysed in lysis buffer. Whole cell lysate was incubated with 5 μg NR4A1 ab#3 antibody (R&D systems; Cat#PP-H1648–00) overnight at 4°C with rotation. Protein A/G magnetic beads were added to the reaction for at least three hours at 4°C. Beads were washed extensively on a magnetic rack, and protein was eluted by heating for 15 minutes at 95°C in reducing sample buffer (Bio-rad) for western blot analysis. Mouse IgG (Millipore; Cat#12–371) was used as negative control for immunoprecipitation. All the co-IP reactions were carried out in the presence of ethidium bromide (1:1000 dilution; ThermoFisher) to avoid possible indirect association with DNA.
+ Open protocol
+ Expand
6

Quantifying TSLP and JAK/STAT Pathway in Mouse Liver

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen mouse liver tissue samples (about 50 mg) were homogenized in 650 mL of TNE buffer (1 mmol/L EDTA, 1% Nonidet P40, 10 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl) containing a phosphatase inhibitors and cocktail of protease (Roche, Basel, Switzerland). The incubation condition was 4°C for 45 min and the centrifugation condition was at 12 000 g for 5 min. BCA Protein Assay (Thermo Fisher, MA, USA) was conducted to quantified protein content was quantified in the supernatant. Reducing sample buffer (Bio-Rad) was used to mix lysates for electrophoresis and subsequently the lysates were transferred onto polyvinylidene fluoride membranes (Thermo Fisher). Equal loading (50 mg) was verified using Ponceau red solution. Antibodies against TSLP (ab188766) was purchased from Abcam (MA, USA) and p-JAK1 (#3331S), JAK1 (#50994S), p-STAT1 (#9167S), STAT1 (#14994S), p-STAT3 (#52075S), STAT3 (#9139S) and anti-β-actin (#3700S) were obtained from Cell Signaling Technology (Danvers, MA, USA). After incubating with HRP-labeled goat anti-rabbit IgG (H+L) (1:3000; Beyotime, Shanghai, China), the Clarity Western ECl Substrate (BioRad, CA, USA) was conducted to proceed immunodetection and the Las-4000 Imaging System and Image MultiGauge software (Fujifilm, Tokyo, Japan) were used to reveal bands.
+ Open protocol
+ Expand
7

Purification and Analysis of Lung CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were immunoaffinity purified from lung homogenates by negative selection using a CD4+ T Cell Isolation Kit (Miltenyi Biotec). To check for bacterial contamination, an aliquot of these cells was diluted in Middlebrook 7H9 medium containing 0.05% SDS for 10 min at room temperature, serially diluted in PBS, plated on Middlebrook 7H11 agar, incubated at 37°C and monitored for growth of bacterial colonies. To further purify T cells, the immunoaffinity-purified cells were washed three times in PBS, stained with AF647 anti-CD3ε mAb and A488 anti-CD11b, and then fixed. From this population, CD11b/CD3ε+ cells were isolated by FACS with a FACSAria (BD Biosciences). Sorted cells were checked for purity by flow cytometry, and analyzed for LAM content by solubilization in reducing sample buffer (Bio-Rad, 5 × 106 cells/ml) followed by SDS-PAGE and western blot analysis as described above (20 µl with 105 cell equivalents was loaded in each lane).
+ Open protocol
+ Expand
8

MR1 and HLA-A,B,C Protein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested in cell lysis buffer (50 mM NaCl, 50 mM TRIS pH8, 1% IGEPAL, 1% Triton X-100) supplemented with protease inhibitor cocktail (Sigma) and allowed to incubate on ice for 20 mins. Lysates were then centrifuged (16,000 × g for 20 min at 4°C) and the supernatant collected. Lysates were mock or Endo H (NEB) digested according to the manufacturer’s instructions for 90 mins at 37°C as required. Lysates were denatured by heating at 95°C for 5 mins in reducing sample buffer (Bio-Rad) and resolved by SDS-PAGE on precast polyacrylamide gels (Biorad) before immunoblotting onto PVDF membranes. Membranes were probed with the designated primary antibodies in 3% BSA in PBST, followed by incubation with an appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (all Santa Cruz Biotechnology). The following primary antibodies were utilized: anti-MR1 CT (McWilliam et al., 2016 (link)), anti-MR1 and anti-HLA-A, B, C (Abcam), anti-GFP, anti-GAPDH, anti-gD, and anti-ICP0 (all Santa Cruz Biotechnology).
+ Open protocol
+ Expand
9

Western Blot Analysis of Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor cells were plated (5.105 cells/dish) in 10-cm dishes, for 72 h. After this time, adherent cells were harvested and lysed in RIPA buffer; protein preparations (30-40 μg) were resuspended in reducing Sample buffer (Bio-Rad Laboratories, Segrate, Mi, Italy) and heated at 95°C for 5 min. Following electrophoretic separation by SDS-PAGE, proteins were transferred onto nitrocellulose membrane. After blocking, membranes were incubated with the primary antibodies against HDAC-6, SMAD7, α-actin and α-tubulin. Detection was done using horseradish peroxidaseconjugated secondary antibodies, and enhanced chemiluminescence ECL-Prime reagents. Total extracts were normalized by using an anti α-tubulin antibody.
+ Open protocol
+ Expand
10

MR1 Protein Immunoblotting and Endo H Digestion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested in cell lysis buffer (50 mM NaCl, 50 mM TRIS pH8, 1% IGEPAL, 1% Triton X-100) supplemented with protease inhibitor cocktail (Sigma) and allowed to incubate on ice for 20 min. Lysates were then centrifuged (16,000 × g for 20 min at 4°C) and the supernatant collected. Lysates were mock or Endo H (NEB) digested according to the manufacturer’s instructions for 90 min at 37°C as required. Lysates were denatured by heating at 95°C for 5 min in reducing sample buffer (Bio-Rad) and resolved by SDS- PAGE on precast polyacrylamide gels (Bio-Rad) before immunoblotting onto PVDF membranes. Membranes were probed with the designated primary antibodies in 3% BSA in PBST, followed by incubation with an appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (all Santa Cruz Biotechnology) and visualised using Clarity Western ECL Substrate (Bio-Rad). The following primary antibodies were utilised: anti-MR1 CT,51 (link) anti-MR1 (Abcam) and anti-HLA-A, B, C (Abcam), anti-GFP (Santa Cruz Biotechnology), anti-GAPDH (Santa Cruz Biotechnology or ThermoFisher), anti-DDDDK (anti FLAG, Abcam) and anti-ICP27 (Santa Cruz Biotechnology). Immunoblots depicted in Figures 2C and 3B are from the same experiment and depict the same Mock and RAd-Ctrl lanes. Unrelated samples were cropped from Figure 3B.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!